Phenotypic Spectrum of Subclinical Sarcomere-Related Hypertrophic Cardiomyopathy and Transition to Overt Disease
Constantin‐Cristian Topriceanu(University College London), Carolyn Y. Ho(Brigham and Women's Hospital), James Moon(University of Michigan), Anna Axelsson Raja(Copenhagen University Hospital), Gabriella Captur(Royal Free London NHS Foundation Trust)
Cited by 3
Related Papers
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
|Circulation|2016|2k
Truncations of Titin Causing Dilated Cardiomyopathy
|New England Journal of Medicine|2012|1.5k
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
|The Lancet|2020|1.2k
Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement
|Journal of Cardiovascular Magnetic Resonance|2013|1.1k
Cardiovascular Magnetic Resonance in Cardiac Amyloidosis
|Circulation|2005|978